Indoor Overheating and Physiological Strain in Older Adults With COPD
The Impact of Extreme Heat on Individuals Living With Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial of Day-Long Passive Indoor Heat Exposure
During warm weather, homes without air conditioning can stay hot for long periods, and most heat-related health problems in Canada happen indoors rather than outdoors. Health Canada recommends that indoor temperatures not exceed 26 °C in homes occupied by people who are more susceptible to heat. That recommendation is based largely on population-level evidence, and very little is known about how susceptible individuals actually respond, physiologically, when indoor temperatures rise above it.
Older adults living with chronic obstructive pulmonary disease (COPD) are among the groups identified as more susceptible to heat. COPD involves persistent airflow limitation, reduced lung and cardiovascular reserve, and altered cellular stress responses. Despite this, no laboratory study has directly measured how adults with COPD respond to a full day spent indoors in warm conditions.
This randomized crossover trial will measure how older adults with COPD respond to two different indoor environments, each experienced for eight hours on separate days at least one week apart. One day is spent at the recommended indoor temperature limit and the other at a warmer temperature representative of conditions recorded inside Canadian homes during hot weather. Participants remain seated and rest throughout; no exercise or work is performed.
Throughout each day, the research team continuously measures core body temperature, skin temperature, heart rate, and measures blood pressure, lung function, breathlessness, thermal comfort, cognitive performance, and balance at set time points. Blood and urine samples are collected at the start and end of each day. Participants are monitored continuously by trained staff.
The results are intended to strengthen the evidence base behind Canadian indoor temperature guidance and to inform recommendations for protecting people living with chronic lung disease during hot weather.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Nicholas Goulet, MSc
- 電話番号:613-322-9930
- メール:ngoul043@uottawa.ca
研究連絡先のバックアップ
- 名前:Pascal Imbeault, PhD
- メール:imbeault@uottawa.ca
研究場所
-
-
Ontario
-
Ottawa、Ontario、カナダ、K1N 6N5
- University of Ottawa
-
コンタクト:
- Nicholas Goulet, MSc
- 電話番号:613-322-9930
- メール:ngoul043@uottawa.ca
-
コンタクト:
- Glen P Kenny, PhD
- メール:gkenny@uottawa.ca
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Aged 60 to 80 years
- Physician diagnosis of chronic obstructive pulmonary disease made at least 5 years previously
- Clinically stable, with no acute exacerbation or active respiratory infection in the preceding 6 weeks
- Current non-smoker
- Able to communicate in English or French and to provide written informed consent
Exclusion Criteria:
- Physical restriction preventing safe participation, including unstable cardiac or pulmonary disease, uncontrolled hypertension (resting blood pressure exceeding 150/95 mmHg), severe arthritis, renal impairment, active proliferative retinopathy, history of disabling stroke, or intermittent claudication
- Recent change in medications judged by the investigators to make participation inadvisable
- Cardiac abnormalities identified on electrocardiogram during the screening exercise test
- Regular work or exercise in hot environments (heat acclimatized)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
アクティブコンパレータ:Recommended indoor temperature limit (26 °C)
Eight-hour passive seated exposure to an indoor environment maintained at 26 °C and 45% relative humidity, corresponding to the recommended upper indoor temperature limit for heat-susceptible occupants. |
Day-long (8 h) passive exposure in a climate-controlled environmental chamber at a set air temperature and relative humidity. Participants remain seated or resting. |
|
実験的:Indoor overheating (36 °C)
Eight-hour passive seated exposure to an indoor environment maintained at 36 °C and 45% relative humidity, representing warm indoor conditions recorded inside Canadian dwellings without mechanical cooling during heat events. |
Day-long (8 h) passive exposure in a climate-controlled environmental chamber at a set air temperature and relative humidity. Participants remain seated or resting. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Core temperature (Peak)
時間枠:End of 8-hour exposure
|
Peak rectal temperature (15 min average) during exposure. Rectal temperature is measured continuously throughout the simulated indoor overheating exposure. |
End of 8-hour exposure
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Profiles of Mood States (POMS)
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Potential changes in mood (7 subscales of mood: tension, anger, depression, fatigue, confusion, vigor and esteem-related affect). The POMS-40 is a validated, self-administered questionnaire that examines seven distinct aspects of mood state across two positive subscales (Esteem-Related Affect, and Vigor) and five negative subscales (Fatigue, Tension, Confusion, Anger, and Depression), which are described across 40 distinct adjectives. For each individual item, participants were asked to describe "how you feel right now" by responding using a 5-point Likert scale (0 = "Not at all", 1 = "A little", 2 = "Moderately", 3 = "Quite a lot", or 4 = "Extremely"). The values of items associated with a specific subscale (e.g., Fatigue) were summed to calculate its score. |
At the start (hour 0) and end of exposure (hour 8)
|
|
Environmental Symptoms Questionnaire (ESQ)
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Self-reported environmental reactions and medical symptomatology associated with prolonged heat exposure. The ESQ-IV is a validated 68-item, self-administered questionnaire that has been used successfully in identifying symptomatology during exposure to a wide variety of environmental conditions, including heat exposure [24, 25]. Participants are asked to assess and described "how you have been feeling today" by responding to each item using a 6-point Likert scale (0 = "Not at all", 1 = "Slight", 2 = "Somewhat", 3 = "Moderate", 4 = "Quite a bit", or 5 = "Extreme"). Total Symptom Score was calculated from this data by taking the sum of the intensity ratings from all 68 individual items using reverse scores for the three positive items from the list ("I Felt Good", "I Felt Alert", and "I Felt Wide Awake"). |
At the start (hour 0) and end of exposure (hour 8)
|
|
Orthostatic intolerance symptoms assessment
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Cumulative sum of scores on 6 questions asking participant to rank symptoms associated with orthostatic intolerance during the lying to standing tests. All symptoms scored on a scale from 0 (none) to 10 (worst possible) and include feelings of: (1) "dizziness, lightheadedness, feeling faint, or feeling like you might black out"; (2) "Problems with vision (blurring, seeing spots, tunnel vision, etc.)"; (3) "Weakness"; (4) "Fatigue"; (5) "Trouble concentrating"; and (6) "Head and neck discomfort". |
At the start (hour 0) and end of exposure (hour 8)
|
|
Perceived arousal (Felt Arousal Scale)
時間枠:End of 8-hour exposure
|
Perceived arousal assessed using the Felt Arousal Scale, a single-item 6-point numerical rating scale on which participants respond to the question "How worked up are you?" Scores range from a minimum of 1 (low arousal) to a maximum of 6 (high arousal). |
End of 8-hour exposure
|
|
Perceived thirst (Thirst Sensation Scale)
時間枠:End of 8-hour exposure
|
Perceived thirst assessed using the Thirst Sensation Scale, a single-item 9-point numerical rating scale on which participants respond to the question "How thirsty do you feel now?" Scores range from a minimum of 1 to a maximum of 9, with verbal anchors at 1 (not thirsty at all), 3 (a little thirsty), 5 (moderately thirsty), 7 (very thirsty), and 9 (very, very thirsty). |
End of 8-hour exposure
|
|
Thermal sensation (American Society of Heating, Refrigerating and Air-Conditioning Engineers thermal sensation scale)
時間枠:End of 8-hour exposure
|
Thermal sensation assessed using the thermal sensation scale defined in ANSI/ASHRAE Standard 55 (American Society of Heating, Refrigerating and Air-Conditioning Engineers), a single-item 7-point bipolar rating scale on which participants respond to the question "How do you feel right now?" Scores range from a minimum of -3 (cold) to a maximum of +3 (hot), with 0 indicating a neutral thermal sensation. |
End of 8-hour exposure
|
|
Thermal comfort (American Society of Heating, Refrigerating and Air-Conditioning Engineers thermal comfort scale)
時間枠:End of 8-hour exposure
|
Thermal comfort assessed using the thermal comfort scale defined in ANSI/ASHRAE Standard 55 (American Society of Heating, Refrigerating and Air-Conditioning Engineers), a single-item 4-point rating scale on which participants respond to the question "How comfortable do you feel right now?" Scores range from a minimum of 1 (comfortable) to a maximum of 4 (very uncomfortable). |
End of 8-hour exposure
|
|
Change in plasma volume
時間枠:End of 8-hour exposure
|
Change in plasma volume from baseline values calculated from duplicate measurements of hemoglobin and hematocrit at the start and end of each exposure using the technique by Dill and Costill |
End of 8-hour exposure
|
|
Fluid loss
時間枠:End of 8-hour exposure
|
Fluid loss calculated as the change in body mass during each exposure presented as a percentage of baseline body mass (corrected for food consumption) |
End of 8-hour exposure
|
|
Fluid consumption
時間枠:End of 8-hour exposure
|
Average hourly fluid consumption calculated by weighing participant water intake at the start and end of each hour of exposure (normalized to the exposure duration). |
End of 8-hour exposure
|
|
Heart rate variability: RMSSD
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Root mean squared standard deviation of normal-to-normal R-wave to R-wave intervals (RMSSD) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position. RMSSD will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest). |
At the start (hour 0) and end of exposure (hour 8)
|
|
Heart rate variability: SDNN
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Standard deviation of normal-to-normal R-wave to R-wave intervals (SDNN) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position. SDNN will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest). |
At the start (hour 0) and end of exposure (hour 8)
|
|
Rate pressure product
時間枠:End of 8-hour exposure
|
Rate pressure product, an index of myocardial work and strain, calculated as systolic blood pressure x heart rate. |
End of 8-hour exposure
|
|
Diastolic blood pressure
時間枠:End of 8-hour exposure
|
Diastolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures) |
End of 8-hour exposure
|
|
Systolic blood pressure
時間枠:End of 8-hour exposure
|
Systolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures) |
End of 8-hour exposure
|
|
Systolic Response to Standing From Supine
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Systolic blood pressure response to standing evaluated as the difference in blood pressure measured between the standing and supine. Standing systolic blood pressure will be taken as the lowest value of those measured after 60 and 120 seconds of standing. Systolic response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest). |
At the start (hour 0) and end of exposure (hour 8)
|
|
CDC 4-Stage Balance Test (Postural stability)
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
To assess postural stability, participants hold a tablet to their chest, then auditory cues guide participants through four consecutive stances, feet side by side, instep of one foot touching the big toe of the other foot, tandem stand with one foot in front of the other, heel touching toe, and stand on one foot. The balance assessment will be evaluated based on movement detected by an accelerometer integrated into the hardware of the tablet device (Sway Medical Inc). |
At the start (hour 0) and end of exposure (hour 8)
|
|
Executive function (cognitive function)
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of executive function. Participants will complete the Cued Stroop test, in which they are presented a sequence of congruent, neutral and incongruent colour-word tasks. |
At the start (hour 0) and end of exposure (hour 8)
|
|
Memory recall (cognitive function)
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of memory recall. Participants complete both a delayed recall test and a working memory test. |
At the start (hour 0) and end of exposure (hour 8)
|
|
Impulse control (cognitive function)
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of impulse control. Participants will be asked to respond to both "go" and "no-go" visual cues. In response to the "go" cue, participants will initiate a movement of the device. |
At the start (hour 0) and end of exposure (hour 8)
|
|
Reaction time (cognitive function)
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of reaction time. Participants will be asked to initiate a movement of the device in response to a visual cue. |
At the start (hour 0) and end of exposure (hour 8)
|
|
Cardiac response to standing from supine (30:15 Ratio)
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Cardiac response to standing evaluated as the ratio between the highest R-wave to R-wave interval (lowest heart rate) measured at the 30th heart beat after standing from supine (+/- 5 beats) and the lowest R-wave to R-wave interval (highest heart rate) measured at the 15th heart beat after standing (+/- 5 beats). Cardiac response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest). Assessment is performed in the morning prior to and following daytime exposure. |
At the start (hour 0) and end of exposure (hour 8)
|
|
Heart rate (AUC)
時間枠:End of 8-hour exposure
|
Area under the curve of heart rate (in bpm-hours) |
End of 8-hour exposure
|
|
Heart rate (Peak)
時間枠:End of 8-hour exposure
|
Peak Heart rate (15-min average) during the 8-hour exposure |
End of 8-hour exposure
|
|
Core temperature (AUC)
時間枠:End of 8-hour exposure
|
Area under the curve of rectal temperature (in degree-hours) |
End of 8-hour exposure
|
|
Core temperature (hourly)
時間枠:Hourly during the 8-hour exposure
|
Rectal temperature measured at each hour of exposure (15-min average) |
Hourly during the 8-hour exposure
|
|
Mean skin temperature (Peak)
時間枠:End of 8-hour exposure
|
Peak mean skin temperature (15-min average) during the 8-hour exposure |
End of 8-hour exposure
|
|
Mean skin temperature (AUC)
時間枠:End of 8-hour exposure
|
Area under the curve of mean skin temperature (in degree-hours) |
End of 8-hour exposure
|
|
Urine specific gravity
時間枠:At the start (hour 0) and end of exposure (hour 8)
|
Urine specific gravity measured by handheld refractometer |
At the start (hour 0) and end of exposure (hour 8)
|
協力者と研究者
捜査官
捜査官
- スタディディレクター:Glen P Kenny, PhD、University of Ottawa
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- H-08-26-13258
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。